Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Alveolus Bio logo — Harnessing the power of the live biotherapeutics and small m...

Alveolus Bio

Harnessing the power of the live biotherapeutics and small molecules for the prevention and treatment of lung diseases

Founded 2020 United States Boston, United States 9 employees Grant Total: $7.00M Biotechnology

General Information

Company Name Alveolus Bio
Founded Year 2020
Location United States Boston, United States +2
Employees 9
Industries Biotechnology
Funding Stage Grant
Social

Get notified when Alveolus Bio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Alveolus Bio

Alveolus Bio is a biotechnology startup, founded in 2020, with a mission to harness the power of live biotherapeutics and small molecules for the prevention and treatment of lung diseases. The company's pipeline includes preclinical stage live biotherapeutics for Idiopathic Pulmonary Fibrosis (IPF), Chronic Obstructive Pulmonary Disease (COPD), and Non-Cystic Fibrosis Bronchiectasis (NCFBE). Notably, their inhaled delivery method effectively targets the distal regions of the lungs, bypassing first-pass metabolism and enhancing efficacy while reducing adverse effects, setting their drugs apart from other treatments. Recently, they received a grant investment from Innovate Alabama on 09 August 2023. With a team comprising scientists, physicians, and innovators, Alveolus Bio is at the forefront of pioneering FDA-approved therapeutics for lung diseases.

Taxonomy: Biotherapeutics, Lung diseases, Idiopathic Pulmonary Fibrosis (IPF), Chronic Obstructive Pulmonary Disease (COPD), Non-Cystic Fibrosis Bronchiectasis (NCFBE), Preclinical stage, Inhaled delivery, FDA-approved therapeutics, Small molecules, Live biotherapeutics, Distal lung targeting, Drug development, Innovation, Medical research, Efficacy

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
09 Aug 2023
Grant •••••• 1
Investor
15 Feb 2023
Seed Round •••••• - 26 Oct 2021

Alveolus Bio Alternatives & Competitors

Alveolus Bio vs
Salem Chest Specialists
Salem Chest Specialists

Expertly managing and treating a full spectrum of respiratory conditions, from chronic lung diseases...

11-50 employees
Biotechnology, Health Care
Alveolus Bio vs
Avalyn Pharma
Avalyn Pharma United States

Revolutionizing respiratory care with every breath

Series C
58 employees
Biopharma, Biotechnology
Compare Alveolus Bio vs Avalyn Pharma
Alveolus Bio vs
Qureight
Qureight United Kingdom

Enterprise-grade imaging and precision endpoints for clinical trials

Series B
58 employees
Compare Alveolus Bio vs Qureight

FAQ About Alveolus Bio

Harnessing the power of the live biotherapeutics and small molecules for the prevention and treatment of lung diseases
Alveolus Bio was founded in 2020.
Alveolus Bio is headquartered in Boston, United States.
Alveolus Bio operates in the following industries: Biotechnology.
Alveolus Bio has approximately 9 employees.
Alveolus Bio has completed 3 funding rounds, raising a total of $7.00M. The latest funding stage is Grant.
Top alternatives and competitors to Alveolus Bio include Salem Chest Specialists, Avalyn Pharma, Qureight, Kither Biotech, Lung Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Alveolus Bio and Salem Chest Specialists are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Alveolus Bio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy